Summary

Eligibility
for males ages 18-64 (full criteria)
Healthy Volunteers
healthy people welcome
Location
at UCSF
Dates
study started
completion around
Principal Investigator
by Yanett Anaya, M.D. (ucsf)

Description

Summary

The investigators currently lack an understanding of barriers to completing the male factor infertility evaluation. Furthermore, as the investigators continue to expand access to fertility treatment particularly within low-resourced settings, it is important that all aspects of infertility within a couple are equally explored. The COVID-19 pandemic has disproportionately affected low-income communities and communities of color at greater rates in terms of not only disease morbidity/mortality but how medical systems are accessed and care is delivered.

Details

This pilot study was designed to help providers identify barriers to completing the basic infertility work-up in a low resource setting with a focus on accessibility and feasibility of semen analysis testing. As a pilot study, a total of 60 male partners of patients who are seeking infertility treatment at the Zuckerberg San Francisco General Hospital Gynecology clinic will be recruited. Participants will be randomized to completing a semen analysis by either the standard in-clinic test or an at-home sperm testing kit. The investigators hypothesis is that there will be an increase in participants completing their semen analysis when using the at-home sperm testing kit as opposed to having to come to the lab.

Specific Aims:

  1. To identify barriers to completing a semen analysis.
  2. To compare barriers unique to completing an in-clinic versus at-home testing.
  3. To compare satisfaction scores with in-clinic versus at-home testing.
  4. To compare the time to complete the semen analysis with in-clinic versus at-home testing.
  5. To compare the time to initiating treatment after completing in-clinic versus at-home testing.

Patients seen at Zuckerberg San Francisco General who are currently undergoing an infertility evaluation as a part of the basic infertility assessment will be contacted. Consented participants will be randomized to complete an at home vs. lab semen analysis. After the semen analysis is completed, participants will be sent a comprehensive questionnaire regarding their experience, level of satisfaction, and barriers with completion of the recent semen analysis. Participants will be given 3 months to complete the semen analysis. If not completed in this timeframe, participants will be sent a different comprehensive questionnaire regarding their barriers with completion of the semen analysis. Additional clinical questions include time from semen analysis order to completion as well as time from semen analysis completion to start of treatment plan.

Keywords

Healthy, Male Infertility, Infertility, Male, Fertility Disorders, Disparities, Resource limited, Low-resource communities, Infertility, Mail-in semen analysis kit, In-Clinic Semen Analysis Testing

Eligibility

You can join if…

Open to males ages 18-64

  • All English or Spanish speaking male partners of female patients undergoing an infertility work-up evaluation at Zuckerberg San Francisco General Hospital and recommended to undergo a semen analysis as a part of this workup.

You CAN'T join if...

  • If they do not speak English or Spanish they will be excluded
  • If they are under the age of 18 y.o
  • If they are not recommended to undergo a semen analysis as a part of the infertility evaluation
  • If they are unable to produce a semen sample.

Location

  • University of California San Francisco accepting new patients
    San Francisco California 94107 United States

Lead Scientist at University of California Health

  • Yanett Anaya, M.D. (ucsf)
    Associate Professor, Ob/Gyn, Reproductive Sciences, School of Medicine. Authored (or co-authored) 6 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT05205733
Study Type
Interventional
Participants
Expecting 60 study participants
Last Updated